The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia

The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment

NCT00103948 ·Status: COMPLETED ·Phase: PHASE2

Evaluating The Impact Of Donepezil Hydrochloride (Aricept) On Behavioral And Psychological Symptoms In Patients With Severe Alzheimer's Disease

NCT00711204 ·Status: WITHDRAWN ·Phase: PHASE4

Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Factors That Affect Aricept Medication Persistence Rate and the Safety and Efficacy in Patients With Alzheimer's Disease in Clinical Practice

NCT02162264 ·Status: COMPLETED

Post-marketing Surveillance of Donepezil Hydrochloride - Investigation of Long Term Safety and Efficacy of Aricept as Well as Its Proper Use Information in Patients With Dementia With Lewy Bodies (DLB).

NCT02448784 ·Status: COMPLETED

Comparison of 23 mg Donepezil Sustained Release (SR) to 10 mg Donepezil Immediate Release (IR) in Patients With Moderate to Severe Alzheimer's Disease

NCT00478205 ·Status: COMPLETED ·Phase: PHASE3

Quality Of Life Assessment In Alzheimer's Disease (AD) Patients Receiving Aricept Tablets

NCT01089582 ·Status: COMPLETED

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

NCT00934375 ·Status: COMPLETED ·Phase: PHASE4

A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI

NCT00483028 ·Status: COMPLETED ·Phase: NA

Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's Disease

NCT00842816 ·Status: COMPLETED ·Phase: PHASE2

Donepezil HCl & Cognitive Deficits in Autism

NCT00047697 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of Donepezil Hydrochloride (Aricept) in Vascular Dementia

NCT00165763 ·Status: COMPLETED ·Phase: PHASE4

A Multi-national Study to Identify Treatment Discontinuation Rate in de Novo Alzheimer's Disease Patients Who Have Been Newly Prescribed With Donepezil (Aricept) in Asia (ADOS)

NCT02262975 ·Status: COMPLETED

Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil

NCT02822573 ·Status: COMPLETED ·Phase: PHASE3

A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

NCT02345213 ·Status: COMPLETED ·Phase: PHASE4

Drug-Drug Interaction Study With Aricept® (Donepezil)

NCT01042314 ·Status: COMPLETED ·Phase: PHASE1

A Multinational, Multi-center, Randomized, Double-blind, Active Comparator, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Donepezil Transdermal Patch in Patients With Alzheimer's Disease

NCT03197740 ·Status: COMPLETED ·Phase: PHASE3

Treatment for Early Memory Loss

NCT00042172 ·Status: COMPLETED ·Phase: PHASE4

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome

NCT00570128 ·Status: COMPLETED ·Phase: PHASE2

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10

NCT00754013 ·Status: TERMINATED ·Phase: PHASE3

Pharmacokinetic Comparisons of Two Donepezil Formulations

NCT01297036 ·Status: COMPLETED ·Phase: PHASE1

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)

NCT00230568 ·Status: COMPLETED ·Phase: PHASE4

Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease

NCT00911807 ·Status: COMPLETED ·Phase: PHASE2

The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

NCT01024660 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial

NCT00675025 ·Status: TERMINATED ·Phase: PHASE2

Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease

NCT00165737 ·Status: COMPLETED ·Phase: PHASE3